• US: +1 9176726599
  • Login
  • Home
  • >> others
  • >> Biophotonics Market By Technology (Surfa...

Biophotonics Market By Technology (Surface Imaging, Inside Imaging, See-through Imaging, Microscopy, Biosensors, Medical Lasers, Spectromolecular, Other Technologies) and Application (Medical Diagnostics, Medical Therapeutic, Tests & Components, Nonmedical Application): Predictions for the industries and worldwide opportunities from 2022 to 2028

Format: PDF | Pages: 344 | Report ID: MRS1185


Report Description

The global biophotonics market was worth USD 51,006.7 million in 2021 and is expected to be worth USD 72,170.5 million by 2028, growing at a CAGR of 10.5% between 2022 and 2028.

The study of generating and directing light to see, find, and control biological elements is known as biophotonics. It uses light and other forms of radiant radiation to examine how living things' cells and tissues function inside of their bodies. Investigating molecular functions, processes, and structures in biology is done using biophotonics. The study of light-tissue interactions at the micro, nano, and macro-organism levels is utilised in medicine to identify, classify, and treat disorders. The emission, absorption, modification, and detection of radiation from tissues, biomolecules, and biomaterials are also affected by it.

Market Trends

The development of biosensors and increased use in industries outside of medicine are expected to cause a major increase in biophotonics technology during the coming years. Throughout the projected period, market expansion is likely to be fueled by the funding for R&D. As more people become aware of the advantages of biophotonics, it is anticipated that the influence of these factors will increase considerably. Also, as technology develops, the price of biophotonics devices is probably going to go down in the coming years.The identification of human cells and tissues is considerably aided by nanotechnology in the healthcare industry. For instance, using biophotonics to communicate with the directly damaged cells in a cancer patient's body speeds up the healing process. The development of cutting-edge medical technology is driving the biophotonics sector.

The development of novel photoacoustic tomography (PAT) systems, rising use of biophotonics in cell and tissue diagnostics, the introduction of nanotechnology in biophotonics, and an ageing population are the other main causes propelling the development of this business. Viruses and cellular components like proteins and nucleic acids are now the focus of biology research instead of the cell.

Segment Insights

The industry is broken down into a number of categories depending on the technology used, including inside imaging, surface imaging, spectromolecular imaging, microscopy, see-through imaging, medical lasers, biosensors, and other technologies.

As the need for minimally invasive procedures expanded and a variety of biophotonic technologies were used in oncology, cardiology, neurology, and brain imaging, see-through imaging emerged as the market leader in 2020. On the other hand, it is anticipated that the biosensors category will grow at the fastest rate throughout the forecast period. The prevalence of diabetes, rising consumer awareness of food security, and soaring demand for unauthorised access prevention will all have a significant impact on the industry in the coming years.

Competitive Insights

Healthcare organisations are working to offer customers innovative and effective solutions in light of recent technical developments in the imaging industry. As a result, it is anticipated that more fresh faces will join the group in the future. These businesses have employed a range of strategies, including product development, product launch, and acquisition, to establish themselves in the biophotonics market.

For instance, Zeiss expanded its presence in North America in March 2021 by investing USD 180 million in a new R&D, production, sales, and customer service facility there. To better support clients in the fields of materials research, life sciences, and industrial technology, the X-ray Microscopy business and the ZEISS Microscopy Customer Center will be combined within the new site.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products, etc.):

  • Thermo Fisher Scientific Inc.
  • Oxford Technologies
  • Carl Zeiss AG
  • Glenbrook Technologies Inc.
  • Becton, Dickinson, and Company
  • Hamamatsu Photonics K.K.
  • Lumenis Ltd.
  • Olympus Corporation
  • PerkinElmer Inc.
  • Zenalux Biomedical Inc.

Technology Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Surface Imaging
  • Inside Imaging
  • See-through Imaging
  • Microscopy
  • Biosensors
  • Medical Lasers
  • Spectromolecular
  • Other Technologies

Application Coverage (Market Size & Forecast, Main Consumer Analysis, etc.):

  • Medical Diagnostics
  • Medical Therapeutic
  • Tests & Components
  • Nonmedical Application

Region Coverage (Regional Consumption, Demand & Forecast by Countries, etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain, etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina, etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa, etc.)

Frequently Asked Questions

The global biophotonics market was worth USD 51,006.7 million in 2021 and is expected to be worth USD 72,170.5 million by 2028, growing at a CAGR of 10.5% between 2022 and 2028.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global biophotonics market is expected to be worth USD 72,170.5 million by 2028, growing at a CAGR of 10.5% between 2022 and 2028.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
With the development in technological advancements in the imaging business, healthcare companies are attempting to provide clients with efficient and novel products. As a result, it is expected that more new participants will emerge in the future. To gain a footing in the biophotonics business, these players have used a variety of techniques, including product development, product launch, and acquisition.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.